脂肪酸合成酶抑制剂;Fatty Acid Synthase Inhibitors;;InformationTVB-2640 TVB-2640 (ASC-40, FASN-IN-2) is an orally bioavailable, pharmacological fatty acid synthase (FAS/FASN) inhibitor with therapeutic potential in patients with NAFLD and nonalcoholic steatohepatitis.TargetsFAS
靶点:
IC50: 0.052 μM (FASN)
参考文献:
1. Minhyoung Lee, et al. Fatty Acid Synthase inhibition prevents palmitoylation of SARS-CoV2 Spike Protein and improves survival of mice infected with murine hepatitis virus. BioRxiv, December 21, 2020.2. Johan D., et al. Heterocyclic modulators of lipid synthesis. WO2012122391A1.